ALEXANDRA BORSBOOM: Open Payments
NPI 1568822435 · MAGNOLIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,214 in 72 payments from 17 companies in 2025. Trend: 2023 $1,905 · 2024 $1,332 · 2025 $1,214
Food & beverage: $1,214
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $263 |
| AstraZeneca Pharmaceuticals LP | 9 | $239 |
| ABBVIE INC. | 14 | $174 |
| Amgen Inc. | 15 | $156 |
| Exact Sciences Corporation | 4 | $78 |
| Phathom Pharmaceuticals, Inc. | 4 | $47 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Medtronic, Inc. | 2 | $37 |
| PFIZER INC. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
Products named: Wegovy, FARXIGA, OTEZLA, VRAYLAR, Ozempic, AIRSUPRA, Cologuard Collection Kit, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
